Self-Monitoring of Blood Glucose in Noninsulin-Treated Diabetes

This document was published more than 2 years ago. The nature of the evidence may have changed.

Conclusions

The scientific evidence does not show any benefits from systematic self-monitoring of blood glucose (SMBG) with test sticks in people with noninsulin-treated type 2 diabetes. Examples of specific situations where people with noninsulin-treated type diabetes may have reason to use test sticks include symptoms of hypoglycemia, particularly in patients being treated with sulfony-lurea agents and meglininides. Self-monitoring may also be needed for other purposes, eg, educational purposes in conjunction with changes in therapy or acute disease.

A more restrictive use of test sticks in the patient group would reduce costs and would not increase medical risks.

How to cite this report: SBU. Self-monitoring of blood glucose in noninsulin-treated diabetes. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2009. SBU report no 194 (in Swedish).

Download summary

SBU Assessment presents a comprehensive, systematic assessment of available scientific evidence. The certainty of the evidence for each finding is systematically reviewed and graded. Full assessments include economic, social, and ethical impact analyses.

SBU assessments are performed by a team of leading professional practitioners and academics, patient/user representatives and SBU staff. Prior to approval and publication, assessments are reviewed by independent experts, SBU’s Scientific Advisory Committees and Board of Directors.

Published: 4/29/2009
Contact SBU: registrator@sbu.se
Report no: 194
Page updated